The association between personal weight gain goals, provider recommendations, and appropriate gestational weight gain.


Journal

American journal of obstetrics & gynecology MFM
ISSN: 2589-9333
Titre abrégé: Am J Obstet Gynecol MFM
Pays: United States
ID NLM: 101746609

Informations de publication

Date de publication:
11 2020
Historique:
received: 18 05 2020
revised: 30 08 2020
accepted: 16 09 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 25 6 2021
Statut: ppublish

Résumé

Nearly half of all women exceed the 2009 Institute of Medicine guidelines for gestational weight gain. Excess gestational weight gain is associated with adverse pregnancy outcomes. Our objective was to determine whether having a personal gestational weight gain goal consistent with the Institute of Medicine's recommendations for appropriate gestational weight gain and whether having a discussion with one's obstetrical provider regarding that goal were associated with appropriate gestational weight gain. This is a secondary analysis of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be study, a prospective cohort study of nulliparous women. We asked women at their first study visit (between 6 and 13 weeks' gestation) whether they had a gestational weight gain goal and what that goal was. Furthermore, we asked whether their provider discussed a gestational weight gain goal and what that goal was. We classified personal and provider-recommended gestational weight gain goals as consistent or inconsistent with the Institute of Medicine guidelines, taking into account a woman's initial body mass index category (underweight, normal weight, overweight, and obese). We included women with live singleton term deliveries (between 37 and 43 weeks' gestation) in this analysis. We classified the primary outcome, which was gestational weight gain (defined as the difference between first visit weight and final weight before delivery), as inadequate, appropriate, or excessive, based on the Institute of Medicine guidelines and initial body mass index category. We used Student t, Wilcoxon rank-sum, and chi-square tests for bivariable analyses, and multinomial logistic regression was performed to control for confounding variables. Of 6727 eligible women, 3799 (56.5% of all eligible women) stated they had a gestational weight gain goal. Of the 3799 women with a stated goal, 2589 (38.5% of all women) had a goal consistent with the Institute of Medicine's recommendations. In addition, of the 6727 eligible women, 2188 (32.5%) reported that they discussed gestational weight gain with their provider, and 1548 of these (23.0% of all women) recalled that their provider gave a gestational weight gain goal in accordance with the Institute of Medicine guidelines. Although having any gestational weight gain goal was not associated with appropriate gestational weight gain, having a gestational weight gain goal that was consistent with the Institute of Medicine's recommendations was associated with a reduced risk of excessive (adjusted relative risk ratio, 0.77; 95% confidence interval, 0.64-0.92) and inadequate weight gain (adjusted relative risk ratio, 0.66; 95% confidence interval, 0.53-0.82). Conversely, discussing gestational weight gain goals with a provider was not associated with either inadequate or excessive gestational weight gain even if the provider's recommendations for gestational weight gain were consistent with the guidelines. Nulliparas who delivered singleton pregnancies at term who had a personal gestational weight gain goal consistent with the Institute of Medicine's recommendations were less likely to have excessive or inadequate gestational weight gain. Further study is required to evaluate the most effective way to communicate this information to patients.

Sections du résumé

BACKGROUND
Nearly half of all women exceed the 2009 Institute of Medicine guidelines for gestational weight gain. Excess gestational weight gain is associated with adverse pregnancy outcomes.
OBJECTIVE
Our objective was to determine whether having a personal gestational weight gain goal consistent with the Institute of Medicine's recommendations for appropriate gestational weight gain and whether having a discussion with one's obstetrical provider regarding that goal were associated with appropriate gestational weight gain.
STUDY DESIGN
This is a secondary analysis of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be study, a prospective cohort study of nulliparous women. We asked women at their first study visit (between 6 and 13 weeks' gestation) whether they had a gestational weight gain goal and what that goal was. Furthermore, we asked whether their provider discussed a gestational weight gain goal and what that goal was. We classified personal and provider-recommended gestational weight gain goals as consistent or inconsistent with the Institute of Medicine guidelines, taking into account a woman's initial body mass index category (underweight, normal weight, overweight, and obese). We included women with live singleton term deliveries (between 37 and 43 weeks' gestation) in this analysis. We classified the primary outcome, which was gestational weight gain (defined as the difference between first visit weight and final weight before delivery), as inadequate, appropriate, or excessive, based on the Institute of Medicine guidelines and initial body mass index category. We used Student t, Wilcoxon rank-sum, and chi-square tests for bivariable analyses, and multinomial logistic regression was performed to control for confounding variables.
RESULTS
Of 6727 eligible women, 3799 (56.5% of all eligible women) stated they had a gestational weight gain goal. Of the 3799 women with a stated goal, 2589 (38.5% of all women) had a goal consistent with the Institute of Medicine's recommendations. In addition, of the 6727 eligible women, 2188 (32.5%) reported that they discussed gestational weight gain with their provider, and 1548 of these (23.0% of all women) recalled that their provider gave a gestational weight gain goal in accordance with the Institute of Medicine guidelines. Although having any gestational weight gain goal was not associated with appropriate gestational weight gain, having a gestational weight gain goal that was consistent with the Institute of Medicine's recommendations was associated with a reduced risk of excessive (adjusted relative risk ratio, 0.77; 95% confidence interval, 0.64-0.92) and inadequate weight gain (adjusted relative risk ratio, 0.66; 95% confidence interval, 0.53-0.82). Conversely, discussing gestational weight gain goals with a provider was not associated with either inadequate or excessive gestational weight gain even if the provider's recommendations for gestational weight gain were consistent with the guidelines.
CONCLUSION
Nulliparas who delivered singleton pregnancies at term who had a personal gestational weight gain goal consistent with the Institute of Medicine's recommendations were less likely to have excessive or inadequate gestational weight gain. Further study is required to evaluate the most effective way to communicate this information to patients.

Identifiants

pubmed: 33345934
pii: S2589-9333(20)30199-3
doi: 10.1016/j.ajogmf.2020.100231
pmc: PMC10569209
mid: NIHMS1934078
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01322529']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

100231

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD063036
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063037
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001108
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063053
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063046
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063072
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063048
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063047
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063041
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063020
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000153
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Lancet. 2006 Sep 30;368(9542):1164-70
pubmed: 17011943
BMJ Open. 2017 Nov 14;7(11):e018527
pubmed: 29138209
Obstet Gynecol. 2006 Oct;108(4):961-8
pubmed: 17012460
PLoS One. 2018 Oct 5;13(10):e0205268
pubmed: 30289912
Matern Child Health J. 2017 Oct;21(10):1927-1938
pubmed: 28707103
Obstet Gynecol Surv. 2018 Aug;73(8):423-432
pubmed: 30169887
Obstet Gynecol. 2015 Apr;125(4):773-781
pubmed: 25751216
Obstet Gynecol. 2017 Jan;129(1):76-82
pubmed: 27926649
N Z Med J. 2016 Aug 05;129(1439):37-45
pubmed: 27507720
Am J Clin Nutr. 2009 Dec;90(6):1552-8
pubmed: 19812177
Am J Clin Nutr. 2013 Nov;98(5):1218-25
pubmed: 24047920
Cochrane Database Syst Rev. 2015 Jun 15;(6):CD007145
pubmed: 26068707
Matern Child Health J. 2018 Aug;22(8):1127-1134
pubmed: 29450794
Semin Perinatol. 2015 Jun;39(4):296-303
pubmed: 26096078
J Matern Fetal Neonatal Med. 2014 May;27(8):795-800
pubmed: 24047475
Obes Rev. 2017 Apr;18(4):385-399
pubmed: 28177566
Obstet Gynecol. 2013 Jan;121(1):210-2
pubmed: 23262962
Obesity (Silver Spring). 2014 Sep;22(9):1997-2002
pubmed: 24890506
J Womens Health (Larchmt). 2010 Apr;19(4):807-14
pubmed: 20078239
Womens Health Issues. 2016 May-Jun;26(3):321-8
pubmed: 26922386
Am J Obstet Gynecol. 2014 Aug;211(2):137.e1-7
pubmed: 24530820
Diabetes Care. 1999 Apr;22(4):623-34
pubmed: 10189543
Am J Obstet Gynecol. 2015 Apr;212(4):539.e1-539.e24
pubmed: 25648779

Auteurs

Annie M Dude (AM)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL. Electronic address: anniemd@uchicago.edu.

Beth Plunkett (B)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, IL.

William Grobman (W)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University, Evanston, IL.

Christina M Scifres (CM)

Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN.

Brian M Mercer (BM)

Department of Obstetrics and Gynecology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH.

Samuel Parry (S)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Robert M Silver (RM)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT.

Ronald Wapner (R)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University, New York City, NY.

Deborah A Wing (DA)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine, Irvine, CA.

George Saade (G)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX.

Uma Reddy (U)

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, New Haven, CT.

Jay Iams (J)

Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH.

Hyagriv Simhan (H)

Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA.

Michelle A Kominiarek (MA)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University, Evanston, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH